We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$230M
AUM Growth
+$15.6M
Cap. Flow
+$5.46M
Cap. Flow %
2.37%
Top 10 Hldgs %
6.97%
Holding
827
New
263
Increased
114
Reduced
126
Closed
324

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.45M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.42M
3
G icon
Genpact
G
+$1.42M
4
CHRW icon
C.H. Robinson
CHRW
+$1.34M
5
OGE icon
OGE Energy
OGE
+$1.31M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.44M
2
MDLZ icon
Mondelez International
MDLZ
+$1.42M
3
AVT icon
Avnet
AVT
+$1.21M
4
MRVL icon
Marvell Technology
MRVL
+$1.04M
5
XYZ
Block Inc
XYZ
+$987K

Sector Composition

Rank Sector Weight
1 Technology 21.25%
2 Consumer Discretionary 15.35%
3 Healthcare 13.63%
4 Industrials 12.99%
5 Financials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DHR icon
326
Danaher
DHR
$144B
$271K 0.12%
+1,370
New +$266K
OMCL icon
327
Omnicell
OMCL
$1.68B
$266K 0.12%
+9,056
New +$271K
SF
328
Stifel
SF
$12.6B
$264K 0.11%
3,812
-13,449
-78% -$826K
PATH icon
329
UiPath
PATH
$7.8B
$263K 0.11%
20,559
-428
-2% -$5.13K
TRNS icon
330
Transcat
TRNS
$871M
$263K 0.11%
+3,059
New +$250K
ORCL icon
331
Oracle
ORCL
$423B
$262K 0.11%
+1,199
New +$194K
LH icon
332
Labcorp
LH
$25.9B
$260K 0.11%
992
-691
-41% -$168K
FTV icon
333
Fortive
FTV
$18.6B
$260K 0.11%
+4,988
New +$261K
EXE
334
Expand Energy Corp
EXE
$21.5B
$259K 0.11%
+2,219
New +$248K
DASH icon
335
DoorDash
DASH
$93.7B
$259K 0.11%
1,052
-183
-15% -$36.7K
EBAY icon
336
eBay
EBAY
$49.8B
$257K 0.11%
+3,457
New +$245K
PCOR icon
337
Procore
PCOR
$8.67B
$257K 0.11%
+3,758
New +$245K
GRMN
338
Garmin
GRMN
$60B
$255K 0.11%
+1,223
New +$243K
NAGE
339
Niagen Bioscience
NAGE
$247M
$254K 0.11%
17,656
-14,612
-45% -$144K
ASIX icon
340
AdvanSix
ASIX
$444M
$253K 0.11%
+10,643
New +$241K
VCYT icon
341
Veracyte
VCYT
$3.8B
$252K 0.11%
+9,330
New +$270K
RPM icon
342
RPM International
RPM
$15B
$248K 0.11%
+2,254
New +$248K
NYT icon
343
New York Times
NYT
$10.2B
$245K 0.11%
+4,383
New +$232K
ENOV icon
344
Enovis
ENOV
$1.53B
$244K 0.11%
+7,791
New +$258K
ESE icon
345
ESCO Technologies
ESE
$7.92B
$243K 0.11%
+1,267
New +$217K
SNCY
346
DELISTED
Sun Country Airlines
SNCY
$243K 0.11%
+20,682
New +$227K
ESAB icon
347
ESAB
ESAB
$5.71B
$242K 0.11%
+2,011
New +$243K
COKE icon
348
Coca-Cola Consolidated
COKE
$12.8B
$242K 0.11%
+2,169
New +$262K
HOOD icon
349
Robinhood
HOOD
$83.9B
$242K 0.11%
+2,584
New +$153K
UA icon
350
Under Armour Class C
UA
$2.53B
$242K 0.1%
37,221
-19,720
-35% -$116K
12 13
14
15 16

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
APM
Advanced Portfolio Management New York $32.8M AUM 6.64% 1-Year Est. Return
CI
Centerstone Investors New York $31.8M AUM 32.46% 1-Year Est. Return

Sherbrooke Park Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Sherbrooke Park Advisers held 827 positions worth $230M, up 7.3% from $215M the previous quarter. Its ten largest holdings account for 7% of the portfolio.

Sherbrooke Park Advisers's Q2 2025 filing shows 263 new, 114 increased, 126 reduced and 324 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M. The largest sale was Merck, an estimated $1.44M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Sherbrooke Park Advisers's largest Q2 2025 buy was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M.
  • Sherbrooke Park Advisers added most to CMS Energy in Q2 2025, an estimated $1.14M increase.
  • Sherbrooke Park Advisers's biggest Q2 2025 reduction was MasTec, cutting an estimated $947K.
  • Sherbrooke Park Advisers fully exited Merck in Q2 2025, selling an estimated $1.44M.
  • Sherbrooke Park Advisers's ten largest holdings make up 7% of its $230M portfolio in Q2 2025.
  • Sherbrooke Park Advisers opened 263 new positions and closed 324 in Q2 2025.
  • Sherbrooke Park Advisers's portfolio value rose 7.3% quarter-over-quarter to $230M.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.